Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Haloperidol for Headache in the ED
NCT02747511Phase 4Completed
- Sponsor
- Western Michigan University Homer Stryker M.D. School of Medicine
- Start
- Oct 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in Headache and migraine comparing Haloperidol with Placebo (2 arms). Primary endpoint: >50% reduction in pain per Visual Analog Scale (VAS). Started Oct 2015; status: completed.
02
Drugs
haloperidol
03
Conditions
Headachemigraine
Beyond the preview
Go deeper on NCT02747511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02747511.